REG - Inspiration Health - Directorate Change

Inspiration HealthcareAnnouncement

07/12/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231207:nRSG9375Va&default-theme=true

RNS Number : 9375V  Inspiration Healthcare Group PLC  07 December 2023

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

 

Directorate change

Strengthens Board with appointment of Roy Davis as Non-Executive Director and
Chair Designate

 

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology
("med tech") company pioneering best-in-class, specialist neonatal intensive
care medical devices, announces the appointment of Gordon Roy Davis ("Roy") as
a Non-Executive Director and successor to Mark Abrahams. Mark has been Chair
of the Board since June 2015 following the reverse acquisition of Inditherm
plc by Inspiration Healthcare Ltd. Roy will become a Non-Executive Director
with effect from 25 January 2024 and Chair from 21 March 2024, when Mark
Abrahams will step down from the Board of the Company. On joining the Board,
he will be appointed to the Nominations Committee and will succeed Mark
Abrahams as Chair of this Committee.

 

Roy brings a wealth of commercial experience in medical devices companies and
has a proven track record of successfully scaling companies and delivering
substantial value for shareholders. He has held leadership positions at a
number of publicly quoted med tech companies, including CEO of Optos plc, a
leading retinal imaging device manufacturer, from 2008 to 2016 until its sale
to Nikon for £259m in February 2015. From 2007 to 2008, Roy was CEO of Gyrus
Group plc, a leader in minimally invasive surgery and visualisation, until its
acquisition by Olympus Corporation in 2008 for $1.9 billion.

 

He is currently Non-Executive Chair at LungLife AI plc, Foster and Freeman
(the trading name of the Galton group of companies) and Rair Health Ltd and
was until recently, Non-Executive Chair at Medica Group plc until its
acquisition by IK Partners for £269 million earlier this year.

 

Mark Abrahams, Chair of Inspiration Healthcare said: "I am delighted to
welcome Roy to the Board. He has all the necessary credentials to guide the
Company through its next phase of development and I look forward to working
with him during the transition to becoming Chair."

 

Neil Campbell, Chief Executive Officer of Inspiration Healthcare said: "Roy's
proven commercial track record, experience and understanding of the med tech
sector will be incredibly important to the Company as we continue to deliver
our strategy. His knowledge of growing companies on the public markets will
add significant value and makes him an ideal successor to Mark Abrahams. We
look forward to capitalising on his expertise in our space."

 

Roy Davis, Chair designate of Inspiration Healthcare said: "I am delighted to
be joining the Board of Inspiration Healthcare. The Company is addressing a
critical need, providing innovative, lifesaving neonatal technologies and has
the right products and expertise to deliver significant long-term sustainable
growth. I look forward to working with Neil, the Executive team and the rest
of the Board in executing the strategy and delivering the next stage of the
Company's development."

 

In accordance with Schedule 2 (g) of the AIM Rules for Companies, Gordon Roy
Davis (aged 67 years) holds/has held the following directorships/partnerships
in the last five years:

 

 Current directorships/partnerships  Previous directorships/partnerships (last five years)
 LungLifeAI, Inc                     Medica Group plc

 Rair Health Limited                 Edinburgh Molecular Imaging Limited

 Galton Bidco Limited

 Galton Midco Limited

 Galton Topco Limited

 Galton Tradeco Limited

 

In addition to the above, Roy Davis was a director of C-Quential Limited until
his resignation on 28 February 2001. The company entered into a creditors
voluntary liquidation on 11 February 2002 and was subsequently dissolved on 18
August 2007.

 

Gordon Roy Davis holds no ordinary shares in the Company.

 

There are no further disclosures to be made under Schedule 2(g) of the AIM
Rules for Companies.

 

 Inspiration Healthcare Group plc                                                Tel: +44 (0)330
                                                 175 0000
 Neil Campbell, Chief Executive Officer

 Liberum (Nominated Adviser & Broker)                                            Tel: +44 (0)20
                                                 3100 2000
 Phil Walker, Richard Lindley, Will King

 Walbrook PR Ltd (Media and Investor Relations)                                  Tel: +44 (0)20
                                                 7933 8780
 Anna Dunphy/Stephanie Cuthbert/

 Louis Ashe-Jepson

 

About Inspiration Healthcare

Inspiration Healthcare (AIM: IHC) designs, manufactures and markets pioneering
medical technology. Based in the UK, the Company specialises in neonatal
intensive care medical devices, which are addressing a critical need to help
to save the lives and improve the outcomes of patients, starting with the very
first breaths of life.

 

The Company has a broad portfolio of its own products and complementary
distributed products, for use in neonatal intensive care designed to support
even the most premature babies throughout their hospital stay. Its own branded
products range from highly sophisticated capital equipment such as ventilators
for life support through to single-use disposables.

 

The Company sells its products directly to hospitals and healthcare providers
in the UK and Ireland, where it also distributes a range of advanced medical
technologies for infusion therapy.  In the rest of the world the Company has
an established network of distribution partners around the world giving access
to more than 75 countries.

 

The Company operates from its world-class Manufacturing and Technology Centre
in Croydon, South London and from its facility in Hailsham, East Sussex.

 

Further information on Inspiration Healthcare can be found at
https://inspirationhealthcaregroup.com/
(https://inspirationhealthcaregroup.com/) .

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOABRBDDGXGDGXL